REGULATED PRESS RELEASE published on 12/09/2025 at 18:16, 10 months 30 days ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/11/2025 AXA communique sur le nombre total d'actions et de droits de vote composant son capital social conformément aux exigences réglementaires Autorité Des Marchés Financiers Déclaration Droits De Vote Capital Social AXA
BRIEF published on 11/28/2025 at 20:02, 11 months 10 days ago AXA Acquires Majority Stake in Prima Insurance Market AXA Acquisition Prima Stake Solvency II Impact Call/put Options
BRIEF published on 11/28/2025 at 20:02, 11 months 10 days ago AXA conclut l'acquisition majoritaire de Prima Acquisition AXA Marché Européen Solvabilité II Prima
REGULATED PRESS RELEASE published on 11/28/2025 at 19:57, 11 months 10 days ago AXA completes the acquisition of a majority stake in Prima AXA completes acquisition of majority stake in Prima for Euro 0.5 billion, impacting -6 points on Solvency II ratio as expected. Further stake acquisition planned in 2029/2030 Acquisition AXA Transaction Solvency II Prima
REGULATED PRESS RELEASE published on 11/28/2025 at 19:57, 11 months 10 days ago AXA a finalisé l'acquisition d'une participation majoritaire dans Prima AXA finalise acquisition majoritaire dans Prima, impact de -6 points sur ratio Solvabilité II, transaction clôturée conformément aux termes annoncés Acquisition AXA Solvabilité II Transaction Prima
BRIEF published on 11/07/2025 at 18:05, 1 year ago AXA's Share Capital and Voting Rights Update Share Capital Voting Rights AXA Disclosure Regulations
BRIEF published on 11/07/2025 at 18:05, 1 year ago AXA : Répartition des droits de vote et d'actions au 31 octobre 2025 Droits De Vote Capital Social Déclaration De Seuil AMF Regulation Actions AXA
REGULATED PRESS RELEASE published on 11/07/2025 at 18:00, 1 year ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2025 AXA, a French public company, discloses information about its share capital, voting rights, and regulatory requirements in accordance with French law Share Capital Voting Rights AXA Regulations French
REGULATED PRESS RELEASE published on 11/07/2025 at 18:00, 1 year ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/10/2025 AXA annonce le nombre total d'actions et de droits de vote composant son capital social conformément aux réglementations financières en vigueur Droits De Vote Capital Social Actions AXA Réglementations
Published on 11/06/2026 at 22:15, 2 days 9 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:30, 33 minutes ago Hannover Re increases Group profit and confirms full-year guidance
Published on 11/09/2026 at 07:30, 33 minutes ago SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Published on 11/09/2026 at 07:30, 33 minutes ago GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Published on 11/09/2026 at 07:30, 33 minutes ago Nordex Group to enter Albania with 84 MW order from Verbund
Published on 11/09/2026 at 07:30, 33 minutes ago q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards
Published on 11/09/2026 at 07:00, 1 hour 3 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 3 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 3 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 3 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
